Klara Kvorning Ternov, MD

Disclosure information not submitted.

Presentation(s):

• MP48-05: Changes in pituitary–gonadal hormones after enzalutamide or abiraterone plus prednisone in men with castration-resistant prostate cancer (HEAT): results from a randomised clinical trial

  Sunday, May 15, 2022
  2:45 PM – 4:00 PM